CD4 and gastrointestinal stromal tumor: This was achieved by analyzing the expression of CD3+, CD4+, CD8+ and CD20+ lymphocytes in the peritumoral capsule from 80 patients with non-gastrointestinal stromal tumors (non-GIST) STS, in relation to other clinico-pathological variables.